FDA inspection
Solaris Pharma Corporation: FDA inspection ending Jan 9, 2020
FDA inspection 1117923 · No Action Indicated (NAI) · Somerset, NJ
Key facts
| Inspection ID | 1117923 |
|---|---|
| Firm | Solaris Pharma Corporation |
| FEI number | 3012158090 |
| Address | 1031g Us Highway 202 South, Suite 200 |
| City | Somerset |
| State | NJ |
| ZIP | 08873 |
| Country | United States |
| Fiscal year | 2020 |
| Inspection end date | Jan 9, 2020 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data